Related Experiment Video
Updated: Jun 18, 2026
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 11, 2010
[Screening of short peptides that bind specifically to osteosarcoma cells by phage-displayed peptide library]
Guo-hong Zhu1, Bei-yi Liu, Shan-gen Zheng
1Department of Rachidial Diseases, Nanfang Hospital, China. ghzhu68@fimmu.edu.cn
Objective:
To obtain short peptides which bind specifically to osteosarcoma cells os-732 by means of screening from 12 peptide libraries.
Methods:
Osteosarcoma cells os-732 were used as the target cells and osteoblasts as the absorber cells for subtraction biopanning from a 12-mer peptide phage-display library. After 3 rounds of screening, the positive phage clones were identified by cell enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry, and the amino acid sequences were deduced by DNA sequencing.
Results:
Nine positive phage clones screened out of 20 clones showed specific binding with osteosarcoma os-732, but no conserved motif was found in these peptides.
Conclusion:
The specific peptides screened from the phage library may be used as potential candidates as ligands for tumor-targeting therapy. The results also suggested that there are different epitopes on the surface of tumor cells.
Insights
Researchers screened peptide libraries to identify specific binding peptides for osteosarcoma cells. These novel peptides show potential as targeted therapy ligands for osteosarcoma treatment.
Area of Science:
- Biotechnology
- Molecular Biology
- Oncology
Context:
- Osteosarcoma is a primary bone malignancy with limited targeted treatment options.
- Phage display technology enables the discovery of novel peptides with specific cellular affinities.
Purpose:
- To identify and isolate short peptides that specifically bind to osteosarcoma cells (OS-732).
- To screen 12 diverse peptide libraries for potential tumor-targeting ligands.
Summary:
- Subtractive biopanning using osteosarcoma cells and osteoblasts was performed on a 12-mer peptide phage-display library over three screening rounds.
- Positive phage clones were validated using cell enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry, with amino acid sequences determined by DNA sequencing.
- Nine out of twenty screened clones demonstrated specific binding to osteosarcoma OS-732 cells, although no conserved peptide motif was identified.
Impact:
- Identified specific peptides as potential candidates for developing targeted tumor therapy for osteosarcoma.
- The findings suggest the presence of diverse epitopes on the surface of osteosarcoma cells, opening avenues for further research.
More Related Videos
07:32Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020